On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with classic congenital adrenal hyperplasia.1 ...
British Columbia Premier David Eby says Canada should maintain retaliatory measures against the United States — such as ...